Global Structural Heart Devices
Market Report
2024
Structural Heart Devices Market Report 2024 (Global Edition)
Structural heart devices market was valued at USD 11.63 Billion in 2022 and will reach USD 25.47 billion by 2030, registering a CAGR of 10.3% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Structural Heart Devices Market Report 2024.
Global Structural Heart Devices Market Report 2024 Market Size Split by Product (Heart Valve Devices, Annuloplasty Rings, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Syste...
The global structural heart devices market was valued at USD 11.63 Billion in 2022 and will reach USD 25.47 billion by 2030, registering a CAGR of 10.3% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Structural Heart Devices Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.3% |
| Market Split by Product |
|
| Market Split by Procedure |
|
| Market Split by Indication |
|
| Market Split by Age Group |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Structural Heart Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Structural Heart Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Structural Heart Devices Market Report Description
Introduction of Structural Heart Devices
Structural heart/cardiac diseases (SHDs) are structural abnormalities of the heart leading to impaired functioning. They are forms of cardiovascular disease and include heart valve diseases, heart failure, coronary artery disease, hypertrophic cardiomyopathy, congenital heart disease, aortic stenosis, and mitral or tricuspid regurgitation that requires valve repair or replacement. structural heart devices such as heart valve devices, annuloplasty rings, surgical heart valves, transcatheter heart valves, occludes & delivery systems, accessories, and other devices are used to treat these disorders. For a long time, structural heart diseases were treated with open-heart surgery, but now less invasive approaches like structural heart devices such as cardiac catheterizations, Mitraclip, transcatheter aortic valve replacements & transcatheter aortic valve implantations, transcatheter mitral valve replacement, alcohol septal ablation, amplatzer septal occluder, are available for patients. There are several advantages to minimally invasive procedures including fewer complications, less blood loss, shorter procedure times, shorter hospital stays, little to no scarring, decreased pain, and faster recovery
The rising prevalence of structural heart/cardiovascular diseases, technological advancement in structural heart devices, government initiatives for R&D and innovation in structural heart devices, and increasing demand for minimally invasive treatment is boosting the growth of the structural heart devices market.
Factors Affecting Structural Heart Devices Market Growth
-
Rising prevalence of structural heart/cardiovascular diseases:
Cardiovascular disorders or structural heart diseases are the world’s second most significant cause of death according to the world health organization (WHO). Structural heart diseases include heart failure, coronary artery disease, hypertrophic cardiomyopathy, and congenital heart disease. Over the last 10 years, the medical community has generally accepted the term ‘structural heart disease’ as a category of disease. Some structural heart interventions are Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD), Aortic Valve Stenosis, Patent Foramen Ovale (PFO), and other structural heart interventions. Atrial septal defect (ASD) is one of the most common congenital heart defects. The most frequently used percutaneous device to close the defect is the Amplatzer. Ventricular septal defects (VSD) represent another common congenital heart abnormality. Anatomically, VSDs can be divided into perimembranous and muscular defects, the former of which is far more frequent. Often, large VSDs are diagnosed and treated in childhood, however, smaller defects can manifest in adulthood.
As a result, numerous activities are being implemented to reduce the prevalence of cardiovascular/ structural heart disorders. One of the most common causes of heart failure is heart valve dysfunction. In severe situations, degenerative diseases of the aortic and mitral valves and disorders of defective tricuspid valves lead to proper clinical care. Interventions for structural heart disease that are minimally invasive, surgical, or catheter-based have expanded considerably in recent years. Because of the high prevalence of cardiovascular or structural heart diseases, there is strong demand for therapeutic techniques such as angioplasty and cardiac surgery for survival, which opens up prospects for companies that produce structural heart valves and Annuloplasty rings, among other devices.
-
Advanced technology in structural heart devices:
New launched and technologically advanced structural heart devices such as annuloplasty rings, obturators, advanced tissue heart valves, and 3D rotational angiography improve the treatment, which fuels the market growth. Advanced CT scan equipment has a benefit to the catheter technology in the structural heart device market. Because of noninvasive measurements, cardiologists and surgeons can map out the entire coronary tree with a single CT scan. 3D rotational angiography can now be fully integrated into other imaging programs. As a result, transcatheter treatments inside the body are better visualized. A significant 3D integration will be a highly effective corrective treatment for chronic total occlusion (CTO). The adoption of modern 3D rotational angiography is rapidly boosting the demand for structural heart/ cardiac devices. It will also enable the installation of virtual stents and a visual picture of how they will alter the flow. This technology expedites the process, saves money on labor, and enhances structural heart device sales.
The launch of new products and the increasing interest of competitors in this industry is expected to boost the growth of the structural heart devices market. For instance, in February 2023 Medtronic announced the relaunch of its Harmony transcatheter Pulmonary Valve Replacement System a minimally invasive alternative to open heart surgery; also in May 2022 Abbott announced two late-breaking data presentations highlighting, a first-of-its-kind minimally invasive tricuspid heart valve repair device, and Navitor.
The Restraining Factor of Structural Heart Devices:
-
The high cost of structural heart devices can hamper the market:
The high cost of technologically advanced devices is a major restraining factor for market growth. Structural heart diseases require surgery, which is a costly treatment for common people.
The expensive cost of structural heart devices also tempts customers away from the new and improved system and towards alternative systems, which negatively influences their bottom lines. The rising cost of structural heart devices plays a major role in restricting the growth of the structural heart devices market.
Impact of the COVID-19 pandemic on the Structural heart devices market:
The global spread of the COVID-19 pandemic offers new challenges, prompting the implementation of new rules to reserve resources and safeguard the public. The postponement of non-emergent procedures has impacted an already weak population of patients with structural heart diseases and multiple comorbidities that prevented beneficial processes such as Transaortic valve replacement (TAVR), left atrial appendage closure device (LAAC), MitraClip, and CardioMEMS was among the primary strategies implemented by hospitals around the country. The Guidelines were primarily based on the avoidable clinical outcomes that occurred during the COVID-19 era. As our understanding of SARS-CoV-2 has progressed, sophisticated cardiac procedures can be performed safely with careful advanced coordination. The new guidelines released by various major cardiology societies discuss solutions to safely perform procedures to improve outcomes in a patient population with a high acuity of illness during the COVID-19 pandemic era.
On the other hand, the pandemic has disrupted healthcare facilities, and demand for different cardiovascular devices, especially structural cardiac/ heart devices, has surged dramatically due to the increased risk of infection in cardiovascular patients. Furthermore, research conducted during the epidemic indicates that effective medications increased demand for structural heart devices for patient survival.
We have various report editions of Structural Heart Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Structural Heart Devices Market Insights Video
Structural Heart Devices Market News
-
February 2023:
Medtronic announced the relaunch of its Harmony transcatheter Pulmonary Valve Replacement System
Medtronic announced the relaunch of its Harmony transcatheter pulmonary valve (TPV) system, a minimally invasive alternative to open heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). Medtronic stated that the company worked collaboratively with the FDA to remediate the issue and earn FDA approval to return the device to market.
-
May 2022:
The new release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
Royal Philips, a global leader in health technology, announced at EuroPCR the international launch of EchoNavigator 4.0, the new release of its advanced image-guided therapy solution for treating structural heart disease. The latest EchoNavigator release gives unique peri-interventional possibilities by offering a comprehensive set of automated views based on advanced 3D heart models in combination with live fusion imaging.
-
May 2022:
Abbott announced two late-breaking data presentations highlighting
Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its-kind minimally invasive tricuspid heart valve repair device, and Navitor, the company's latest-generation Transcatheter aortic valve implantation (TAVI) system. The company also displayed new data for MitraClip and Amplatzer Amulet, two key components of the company's industry-leading structural heart portfolio.
-
August 2021:
Medtronic Announced FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Medtronic plc, the global leader in medical technology, announced the U.S. Food and Drug Administration (FDA) approval of its new-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system. Designed to enhance ease of use and provide greater precision and control throughout the procedure, the Evolut FX system maintains the industry-leading hemodynamic (blood flow) and durability benefits of the Evolut platform, while bringing product and procedure innovation for patients with symptomatic severe aortic stenosis.
Top Companies Market Share in Structural Heart Devices Industry: (In no particular order of Rank)
- Abbott
- jenavalve technology
- LNC.
- Micro Interventional Devices
- medical technology EST.
- Boston Scientific Corporation
- Livanova
- Edwards Lifesciences Corporation
- Braile Biomédica
- Medtronic
- TTK Healthcare (A TTK Group Company)
- Cryolife
- Lepu Medical Technology
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global structural heart devices:
Structural heart devices held a significant portion of the North American market. One of the main drivers of the sector is the existence of a sizable population who suffer from structural heart diseases. Early detection of structural heart disorders is made possible by the well-established healthcare infrastructure, which also includes a sophisticated and large testing network. There is also quick access to therapy available. Day by day structural heart disease is more prevalent in the middle-aged population which expects to grow the market in this region. An important secondary element that facilitates baby congenital heart disease early detection and treatment is well-established pediatric care, structured heart device R&D are the main priorities of large pharmaceutical and biotechnology businesses. Many scientific advancements enabled by a strong scientific community and research infrastructure have resulted in the invention of sophisticated, minimally invasive, and highly effective structured heart devices. The robust insurance protection system and governmental healthcare initiatives contribute to market growth.
During the projection period, strong growth is predicted in the Asia Pacific. Rising healthcare facility demand, a favorable reimbursement environment, and increased regional knowledge of structural heart diseases all favorably affect the structural heart device market. Additionally, the presence of a large population pool in this region suffering from cardiac problems helps market expansion.
The current report Scope analyzes Structural Heart Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Structural Heart Devices Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Structural Heart Devices Market Analysis
Global Structural Heart Devices Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Structural Heart Devices Industry growth. Structural Heart Devices market has been segmented with the help of its Product , Procedure Indication , and others. Structural Heart Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By product, the heart valve devices segment accounted for the largest revenue share of the structural heart devices market:
By product, the structural heart device market is segmented into heart valve devices, surgical heart valves, transcatheter heart valves, annuloplasty rings, occludes & delivery systems, accessories, and other devices. The market for heart valve devices is massive and continuously expanding. The continuing adoption and commercialization of innovative devices, as well as the continuously rising pool of elderly cardiovascular/structural heart disease patients primarily drive it. A growing pool of favorable clinical evidence is also bolstering demand for heart valve implants. Furthermore, the competitive landscape in this category is constantly altering, with few innovative companies being bought regularly by cash-rich and established market heavyweights. The pipeline of heart valve devices is also strong, with new long-lasting devices expected to be introduced in the future year.
- Heart Valve Devices
- Annuloplasty Rings
- Surgical Heart Valves
- Transcatheter Heart Valves
- Occluders & Delivery Systems
- Accessories
- Other Devices
Structural Heart Devices Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Structural Heart Devices Industry. Request a Free Sample PDF!
Procedure Segment Analysis of Structural Heart Devices Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Structural Heart Devices from 2019 to 2031. This will also help to analyze the demand for Structural Heart Devices across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Procedure of Structural Heart Devices are:
- Replacement Procedures
- Repair Procedures
Structural Heart Devices Market Share (%) by Procedure in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Structural Heart Devices Indication Segment Analysis
By indication the aortic valve stenosis segment dominated the worldwide structural heart devices market revenue share:
Based on the indication market is segmented into Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD), Aortic Valve Stenosis, Patent Foramen Ovale (PFO), and Others.
Structural heart devices are majorly used in aortic valve stenosis disease which increases the market. Aortic valve stenosis or aortic stenosis is a type of heart valve disease (valvular heart disease). The valve between the lower left heart chamber and the body's main artery (aorta) is narrowed and does not open fully. This reduces or blocks blood flow from the heart to the aorta and the rest of the body. Treatment of aortic stenosis depends on the severity of the condition. in severe condition need surgery to repair or replace the valve. Without treatment, severe aortic valve stenosis can lead to death. Aortic valve stenosis causes Congenital heart defects, Calcium build-up on the valve (aortic valve calcification), and Rheumatic fever. Due to older age, certain heart conditions present at birth (congenital heart defects), such as a bicuspid aortic valve, chronic kidney disease, Having heart diseases risk factors, (such as diabetes, high cholesterol, and high blood pressure). Furthermore, a history of infections that can affect the heart, such as rheumatic fever and infective endocarditis, History of radiation therapy to the chest increases aortic valve stenosis. Due to all these factors demand for structural heart devices increased which fuel the market growth.
- Ventricular Septal Defect (VSD)
- Atrial Septal Defect (ASD)
- Aortic Valve Stenosis
- Patent Foramen Ovale (PFO)
- Others
Structural Heart Devices Age Group Segment Analysis
- Pediatric
- Adults
Structural Heart Devices End User Segment Analysis
- Hospitals
- Ambulatory Surgical Centers
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Structural Heart Devices Market is witnessing significant growth in the near future.
In 2023, the Heart Valve Devices segment accounted for noticeable share of global Structural Heart Devices Market and is projected to experience significant growth in the near future.
The Replacement Procedures segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott , LNC. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Structural Heart Devices Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Structural Heart Devices Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Heart Valve Devices, Annuloplasty Rings, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems, Accessories, Other Devices |
| Procedure | Replacement Procedures, Repair Procedures |
| Indication | Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD), Aortic Valve Stenosis, Patent Foramen Ovale (PFO), Others |
| Age Group | Pediatric, Adults |
| End User | Hospitals, Ambulatory Surgical Centers |
| List of Competitors | Abbott, jenavalve technology, LNC., Micro Interventional Devices, medical technology EST., Boston Scientific Corporation, Livanova, Edwards Lifesciences Corporation, Braile Biomédica, Medtronic, TTK Healthcare (A TTK Group Company), Cryolife, Lepu Medical Technology |
This chapter will help you gain GLOBAL Market Analysis of Structural Heart Devices. Further deep in this chapter, you will be able to review Global Structural Heart Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Structural Heart Devices Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Structural Heart Devices Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Structural Heart Devices Revenue Market Size By Region
-
-
1.3 Global Structural Heart Devices Market Size By Product 2019 -2031
-
1.3.1 Heart Valve Devices Market Size
-
1.3.2 Annuloplasty Rings Market Size
-
1.3.3 Surgical Heart Valves Market Size
-
1.3.4 Transcatheter Heart Valves Market Size
-
1.3.5 Occluders & Delivery Systems Market Size
-
1.3.6 Accessories Market Size
-
1.3.7 Other Devices Market Size
-
-
1.4 Global Structural Heart Devices Market Size By Procedure 2019 -2031
-
1.4.1 Replacement Procedures Market Size
-
1.4.2 Repair Procedures Market Size
-
-
1.5 Global Structural Heart Devices Market Size By Indication 2019 -2031
-
1.5.1 Ventricular Septal Defect (VSD) Market Size
-
1.5.2 Atrial Septal Defect (ASD) Market Size
-
1.5.3 Aortic Valve Stenosis Market Size
-
1.5.4 Patent Foramen Ovale (PFO) Market Size
-
1.5.5 Others Market Size
-
-
1.6 Global Structural Heart Devices Market Size By Age Group for 2019 -2031
-
1.6.1 Pediatric Market Size
-
1.6.2 Adults Market Size
-
-
1.7 Global Structural Heart Devices Market Size By End User for 2019 -2031
-
1.7.1 Hospitals Market Size
-
1.7.2 Ambulatory Surgical Centers Market Size
-
-
1.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.9 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.9.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.9.2 Global Market Revenue Split By Product
-
1.9.3 Global Market Revenue Split By Procedure
-
1.9.4 Global Market Revenue Split By Indication
-
1.9.5 Global Market Revenue Split By Age Group
-
1.9.6 Global Market Revenue Split By End User
-
1.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Structural Heart Devices Market Size 2019 - 2031
-
2.1.1 North America Structural Heart Devices Market Size By Country 2019 - 2031
-
2.1.2 North America Structural Heart Devices Market Size by Product 2019 -2031
-
2.1.2.1 North America Heart Valve Devices Market Size
-
2.1.2.2 North America Annuloplasty Rings Market Size
-
2.1.2.3 North America Surgical Heart Valves Market Size
-
2.1.2.4 North America Transcatheter Heart Valves Market Size
-
2.1.2.5 North America Occluders & Delivery Systems Market Size
-
2.1.2.6 North America Accessories Market Size
-
2.1.2.7 North America Other Devices Market Size
-
-
2.1.3 North America Structural Heart Devices Market Size by Procedure 2019 -2031
-
2.1.3.1 North America Replacement Procedures Market Size
-
2.1.3.2 North America Repair Procedures Market Size
-
-
2.1.4 North America Structural Heart Devices Market Size by Indication 2019 -2031
-
2.1.4.1 North America Ventricular Septal Defect (VSD) Market Size
-
2.1.4.2 North America Atrial Septal Defect (ASD) Market Size
-
2.1.4.3 North America Aortic Valve Stenosis Market Size
-
2.1.4.4 North America Patent Foramen Ovale (PFO) Market Size
-
2.1.4.5 North America Others Market Size
-
-
2.1.5 North America Structural Heart Devices Market Size by Age Group 2019 -2031
-
2.1.5.1 North America Pediatric Market Size
-
2.1.5.2 North America Adults Market Size
-
-
2.1.6 North America Structural Heart Devices Market Size by End User 2019 -2031
-
2.1.6.1 North America Hospitals Market Size
-
2.1.6.2 North America Ambulatory Surgical Centers Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Structural Heart Devices Market Size 2019 - 2031
-
3.1.1 Europe Structural Heart Devices Market Size By Country 2019 - 2031
-
3.1.2 Europe Structural Heart Devices Market Size by Product 2019 -2031
-
3.1.2.1 Europe Heart Valve Devices Market Size
-
3.1.2.2 Europe Annuloplasty Rings Market Size
-
3.1.2.3 Europe Surgical Heart Valves Market Size
-
3.1.2.4 Europe Transcatheter Heart Valves Market Size
-
3.1.2.5 Europe Occluders & Delivery Systems Market Size
-
3.1.2.6 Europe Accessories Market Size
-
3.1.2.7 Europe Other Devices Market Size
-
-
3.1.3 Europe Structural Heart Devices Market Size by Procedure 2019 -2031
-
3.1.3.1 Europe Replacement Procedures Market Size
-
3.1.3.2 Europe Repair Procedures Market Size
-
-
3.1.4 Europe Structural Heart Devices Market Size by Indication 2019 -2031
-
3.1.4.1 Europe Ventricular Septal Defect (VSD) Market Size
-
3.1.4.2 Europe Atrial Septal Defect (ASD) Market Size
-
3.1.4.3 Europe Aortic Valve Stenosis Market Size
-
3.1.4.4 Europe Patent Foramen Ovale (PFO) Market Size
-
3.1.4.5 Europe Others Market Size
-
-
3.1.5 Europe Structural Heart Devices Market Size by Age Group 2019 -2031
-
3.1.5.1 Europe Pediatric Market Size
-
3.1.5.2 Europe Adults Market Size
-
-
3.1.6 Europe Structural Heart Devices Market Size by End User 2019 -2031
-
3.1.6.1 Europe Hospitals Market Size
-
3.1.6.2 Europe Ambulatory Surgical Centers Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Structural Heart Devices Market Size 2019 - 2031
-
4.1.1 Asia Pacific Structural Heart Devices Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Structural Heart Devices Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Heart Valve Devices Market Size
-
4.1.2.2 Asia Pacific Annuloplasty Rings Market Size
-
4.1.2.3 Asia Pacific Surgical Heart Valves Market Size
-
4.1.2.4 Asia Pacific Transcatheter Heart Valves Market Size
-
4.1.2.5 Asia Pacific Occluders & Delivery Systems Market Size
-
4.1.2.6 Asia Pacific Accessories Market Size
-
4.1.2.7 Asia Pacific Other Devices Market Size
-
-
4.1.3 Asia Pacific Structural Heart Devices Market Size by Procedure 2019 -2031
-
4.1.3.1 Asia Pacific Replacement Procedures Market Size
-
4.1.3.2 Asia Pacific Repair Procedures Market Size
-
-
4.1.4 Asia Pacific Structural Heart Devices Market Size by Indication 2019 -2031
-
4.1.4.1 Asia Pacific Ventricular Septal Defect (VSD) Market Size
-
4.1.4.2 Asia Pacific Atrial Septal Defect (ASD) Market Size
-
4.1.4.3 Asia Pacific Aortic Valve Stenosis Market Size
-
4.1.4.4 Asia Pacific Patent Foramen Ovale (PFO) Market Size
-
4.1.4.5 Asia Pacific Others Market Size
-
-
4.1.5 Asia Pacific Structural Heart Devices Market Size by Age Group 2019 -2031
-
4.1.5.1 Asia Pacific Pediatric Market Size
-
4.1.5.2 Asia Pacific Adults Market Size
-
-
4.1.6 Asia Pacific Structural Heart Devices Market Size by End User 2019 -2031
-
4.1.6.1 Asia Pacific Hospitals Market Size
-
4.1.6.2 Asia Pacific Ambulatory Surgical Centers Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Structural Heart Devices Market Size 2019 - 2031
-
5.1.1 South America Structural Heart Devices Market Size By Country 2019 - 2031
-
5.1.2 South America Structural Heart Devices Market Size by Product 2019 -2031
-
5.1.2.1 South America Heart Valve Devices Market Size
-
5.1.2.2 South America Annuloplasty Rings Market Size
-
5.1.2.3 South America Surgical Heart Valves Market Size
-
5.1.2.4 South America Transcatheter Heart Valves Market Size
-
5.1.2.5 South America Occluders & Delivery Systems Market Size
-
5.1.2.6 South America Accessories Market Size
-
5.1.2.7 South America Other Devices Market Size
-
-
5.1.3 South America Structural Heart Devices Market Size by Procedure 2019 -2031
-
5.1.3.1 South America Replacement Procedures Market Size
-
5.1.3.2 South America Repair Procedures Market Size
-
-
5.1.4 South America Structural Heart Devices Market Size by Indication 2019 -2031
-
5.1.4.1 South America Ventricular Septal Defect (VSD) Market Size
-
5.1.4.2 South America Atrial Septal Defect (ASD) Market Size
-
5.1.4.3 South America Aortic Valve Stenosis Market Size
-
5.1.4.4 South America Patent Foramen Ovale (PFO) Market Size
-
5.1.4.5 South America Others Market Size
-
-
5.1.5 South America Structural Heart Devices Market Size by Age Group 2019 -2031
-
5.1.5.1 South America Pediatric Market Size
-
5.1.5.2 South America Adults Market Size
-
-
5.1.6 South America Structural Heart Devices Market Size by End User 2019 -2031
-
5.1.6.1 South America Hospitals Market Size
-
5.1.6.2 South America Ambulatory Surgical Centers Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Structural Heart Devices Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Structural Heart Devices Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Structural Heart Devices Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Heart Valve Devices Market Size
-
6.1.2.2 Middle East and Africa Annuloplasty Rings Market Size
-
6.1.2.3 Middle East and Africa Surgical Heart Valves Market Size
-
6.1.2.4 Middle East and Africa Transcatheter Heart Valves Market Size
-
6.1.2.5 Middle East and Africa Occluders & Delivery Systems Market Size
-
6.1.2.6 Middle East and Africa Accessories Market Size
-
6.1.2.7 Middle East and Africa Other Devices Market Size
-
-
6.1.3 Middle East and Africa Structural Heart Devices Market Size by Procedure 2019 -2031
-
6.1.3.1 middle_east_and_africa_title} Replacement Procedures Market Size
-
6.1.3.2 middle_east_and_africa_title} Repair Procedures Market Size
-
-
6.1.4 Middle East and Africa Structural Heart Devices Market Size by Indication 2019 -2031
-
6.1.4.1 Middle East and Africa Ventricular Septal Defect (VSD) Market Size
-
6.1.4.2 Middle East and Africa Atrial Septal Defect (ASD) Market Size
-
6.1.4.3 Middle East and Africa Aortic Valve Stenosis Market Size
-
6.1.4.4 Middle East and Africa Patent Foramen Ovale (PFO) Market Size
-
6.1.4.5 Middle East and Africa Others Market Size
-
-
6.1.5 Middle East and Africa Structural Heart Devices Market Size by Age Group 2019 -2031
-
6.1.5.1 Middle East and Africa Pediatric Market Size
-
6.1.5.2 Middle East and Africa Adults Market Size
-
-
6.1.6 Middle East and Africa Structural Heart Devices Market Size by End User 2019 -2031
-
6.1.6.1 Middle East and Africa Hospitals Market Size
-
6.1.6.2 Middle East and Africa Ambulatory Surgical Centers Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Structural Heart Devices Market Size by Product 2019 -2031
-
7.1.2 Country 1Structural Heart Devices Market Size by Procedure 2019 -2031
-
7.1.3 Country 1Structural Heart Devices Market Size by Indication 2019 -2031
-
7.1.4 Country 1Structural Heart Devices Market Size by Age Group 2019 -2031
-
7.1.5 Country 1Structural Heart Devices Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Structural Heart Devices Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 jenavalve technology
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 LNC.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Micro Interventional Devices
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 medical technology EST.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Boston Scientific Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Livanova
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Edwards Lifesciences Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Braile Biomédica
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Medtronic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 TTK Healthcare (A TTK Group Company)
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Cryolife
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Lepu Medical Technology
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Analysis 2019 -2031, will provide market size split by Product . This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Heart Valve Devices
-
10.1.1 Global Structural Heart Devices Revenue Market Size and Share by Heart Valve Devices 2019 -2031
-
-
10.2 Annuloplasty Rings
-
10.2.1 Global Structural Heart Devices Revenue Market Size and Share by Annuloplasty Rings 2019 -2031
-
-
10.3 Surgical Heart Valves
-
10.3.1 Global Structural Heart Devices Revenue Market Size and Share by Surgical Heart Valves 2019 -2031
-
-
10.4 Transcatheter Heart Valves
-
10.4.1 Global Structural Heart Devices Revenue Market Size and Share by Transcatheter Heart Valves 2019 -2031
-
-
10.5 Occluders & Delivery Systems
-
10.5.1 Global Structural Heart Devices Revenue Market Size and Share by Occluders & Delivery Systems 2019 -2031
-
-
10.6 Accessories
-
10.6.1 Global Structural Heart Devices Revenue Market Size and Share by Accessories 2019 -2031
-
-
10.7 Other Devices
-
10.7.1 Global Structural Heart Devices Revenue Market Size and Share by Other Devices 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Procedure Analysis 2019 -2031
-
11.1 Replacement Procedures
-
11.1.1 Global Structural Heart Devices Revenue Market Size and Share by Replacement Procedures 2019 - 2031
-
-
11.2 Repair Procedures
-
11.2.1 Global Structural Heart Devices Revenue Market Size and Share by Repair Procedures 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Indication Analysis 2019 -2031
-
12.1 Ventricular Septal Defect (VSD)
-
12.1.1 Global Structural Heart Devices Revenue Market Size and Share by Ventricular Septal Defect (VSD) 2019 -2031
-
-
12.2 Atrial Septal Defect (ASD)
-
12.2.1 Global Structural Heart Devices Revenue Market Size and Share by Atrial Septal Defect (ASD) 2019 -2031
-
-
12.3 Aortic Valve Stenosis
-
12.3.1 Global Structural Heart Devices Revenue Market Size and Share by Aortic Valve Stenosis 2019 -2031
-
-
12.4 Patent Foramen Ovale (PFO)
-
12.4.1 Global Structural Heart Devices Revenue Market Size and Share by Patent Foramen Ovale (PFO) 2019 -2031
-
-
12.5 Others
-
12.5.1 Global Structural Heart Devices Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Age Group Analysis 2019 -2031
-
13.1 Pediatric
-
13.1.1 Global Structural Heart Devices Revenue Market Size and Share by Pediatric 2019 -2031
-
-
13.2 Adults
-
13.2.1 Global Structural Heart Devices Revenue Market Size and Share by Adults 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End User Analysis 2019 -2031
-
14.1 Hospitals
-
14.1.1 Global Structural Heart Devices Revenue Market Size and Share by Hospitals 2019 -2031
-
-
14.2 Ambulatory Surgical Centers
-
14.2.1 Global Structural Heart Devices Revenue Market Size and Share by Ambulatory Surgical Centers 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Structural Heart Devices market
Chapter 15 Research Findings
-
15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
15.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Structural Heart Devices Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Structural Heart Devices Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Structural Heart Devices Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Structural Heart Devices Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Structural Heart Devices Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Structural Heart Devices Market
Key Questions Answered By Structural Heart Devices Market Report 2024
| Why Heart Valve Devices have a significant impact on Structural Heart Devices market? |
| What are the key factors affecting the Heart Valve Devices and Annuloplasty Rings of Structural Heart Devices Market? |
| What is the CAGR/Growth Rate of Replacement Procedures during the forecast period? |
| By type, which segment accounted for largest share of the global Structural Heart Devices Market? |
| Which region is expected to dominate the global Structural Heart Devices Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
